bioAffinity Technologies Appoints New Science Team

PUBLISHED ON April 4, 2016

SAN ANTONIO, TX (April 4, 2016) bioAffinity Technologies, a privately held cancer diagnostics company, today announced that Vivienne Rebel, M.D., Ph.D., has joined the Company as Executive Vice President of Research and Development (R&D) and Chief Medical and Science Officer.

read more

bioAffinity Technologies Announces Patent Award in China

PUBLISHED ON December 14, 2015

SAN ANTONIO, TX (December 14, 2015) bioAffinity Technologies announced the People’s Republic of China awarded a Certificate of Invention Patent for the Company’s proprietary CyPath® assay, a bio-label that preferentially binds to cancer cells and labels them a brilliant crimson red that can be detected and measured by fluorescent imaging.

read more

bioAffinity Technologies was selected as one of San Antonio’s Top 2020 Innovators. In this video, you will see Maria Zannes, President and Chief Executive Officer, speak about what drives motivation, innovation and success and kick off San Antonio’s premier annual event celebrating the City’s healthcare and bioscience industry.

 

www.thehealthcell.org/sitepage/state-of-the-industry/